These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 31710433)

  • 41. A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysis.
    Chen Y; Zhang J; Guo L; Liu L; Wen J; Xu L; Yan M; Li Z; Zhang X; Nan P; Jiang J; Ji J; Zhang J; Cai W; Zhuang H; Wang Y; Zhu Z; Yu Y
    Oncotarget; 2016 Dec; 7(52):87496-87510. PubMed ID: 27589838
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Performance of a multiplexed dual analyte immunoassay for the early detection of non-small cell lung cancer.
    Doseeva V; Colpitts T; Gao G; Woodcock J; Knezevic V
    J Transl Med; 2015 Feb; 13():55. PubMed ID: 25880432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Urinary metallomics as a novel biomarker discovery platform: Breast cancer as a case study.
    Burton C; Dan Y; Donovan A; Liu K; Shi H; Ma Y; Bosnak CP
    Clin Chim Acta; 2016 Jan; 452():142-8. PubMed ID: 26585752
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Diagnostic accuracy of urine HE4 in patients with ovarian cancer: a meta-analysis.
    Jia MM; Deng J; Cheng XL; Yan Z; Li QC; Xing YY; Fan DM; Tian XY
    Oncotarget; 2017 Feb; 8(6):9660-9671. PubMed ID: 28039447
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of human telomerase reverse transcriptase mRNA in urine of patients with bladder cancer: evaluation of an emerging tumor marker.
    Melissourgos N; Kastrinakis NG; Davilas I; Foukas P; Farmakis A; Lykourinas M
    Urology; 2003 Aug; 62(2):362-7. PubMed ID: 12893365
    [TBL] [Abstract][Full Text] [Related]  

  • 46. One-view breast tomosynthesis versus two-view mammography in the Malmö Breast Tomosynthesis Screening Trial (MBTST): a prospective, population-based, diagnostic accuracy study.
    Zackrisson S; Lång K; Rosso A; Johnson K; Dustler M; Förnvik D; Förnvik H; Sartor H; Timberg P; Tingberg A; Andersson I
    Lancet Oncol; 2018 Nov; 19(11):1493-1503. PubMed ID: 30322817
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Noninvasive Diagnosis of Pancreatic Cancer Through Detection of Volatile Organic Compounds in Urine.
    Arasaradnam RP; Wicaksono A; O'Brien H; Kocher HM; Covington JA; Crnogorac-Jurcevic T
    Gastroenterology; 2018 Feb; 154(3):485-487.e1. PubMed ID: 29129714
    [No Abstract]   [Full Text] [Related]  

  • 48. A multiplex immunoassay for the non-invasive detection of bladder cancer.
    Shimizu Y; Furuya H; Bryant Greenwood P; Chan O; Dai Y; Thornquist MD; Goodison S; Rosser CJ
    J Transl Med; 2016 Jan; 14():31. PubMed ID: 26830497
    [TBL] [Abstract][Full Text] [Related]  

  • 49. DR-70 as a novel diagnostic biomarker for gastric cancer.
    Arhan M; Yılmaz H; Önal İK; Kocabıyık M; Erdal H; İbiş M
    Turk J Gastroenterol; 2015 Nov; 26(6):480-3. PubMed ID: 26575041
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Correlation between Faecal Tumour M2 Pyruvate Kinase and Colonoscopy for the Detection of Adenomatous Neoplasia in a Secondary Care Cohort.
    Bond AD; Burkitt MD; Sawbridge D; Corfe BM; Probert CS
    J Gastrointestin Liver Dis; 2016 Mar; 25(1):71-7. PubMed ID: 27014756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hyaluronic acid and hyaluronidase as possible novel urine biomarkers for the diagnosis of prostate cancer.
    Skarmoutsos I; Skarmoutsos A; Katafigiotis I; Tataki E; Giagini A; Adamakis I; Alamanis C; Duvdevani M; Sitaras N; Constantinides C
    Med Oncol; 2018 May; 35(7):97. PubMed ID: 29802604
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Identification of highly sensitive biomarkers that can aid the early detection of pancreatic cancer using GC/MS/MS-based targeted metabolomics.
    Hirata Y; Kobayashi T; Nishiumi S; Yamanaka K; Nakagawa T; Fujigaki S; Iemoto T; Kobayashi M; Okusaka T; Nakamori S; Shimahara M; Ueno T; Tsuchida A; Sata N; Ioka T; Yasunami Y; Kosuge T; Kaneda T; Kato T; Yagihara K; Fujita S; Yamada T; Honda K; Azuma T; Yoshida M
    Clin Chim Acta; 2017 May; 468():98-104. PubMed ID: 28215548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Carbonic anhydrase IX as a diagnostic urinary marker for urothelial bladder cancer.
    de Martino M; Lucca I; Mbeutcha A; Wiener HG; Haitel A; Susani M; Shariat SF; Klatte T
    Eur Urol; 2015 Oct; 68(4):552-4. PubMed ID: 26138037
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Overestimation of nuclear matrix protein 22 in concentrated urine.
    Joung JY; Park S; Yoon H; Kwon WA; Cho IC; Seo HK; Chung J; Hwang SH; Lee CW; Lee KH
    Urology; 2013 Nov; 82(5):1059-64. PubMed ID: 24044907
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Screening, identification of prostate cancer urinary biomarkers and verification of important spots.
    Zhao H; Zhao X; Lei T; Zhang M
    Invest New Drugs; 2019 Oct; 37(5):935-947. PubMed ID: 30610587
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Detection of Colorectal Cancer Using a Simplified SEPT9 Gene Methylation Assay Is a Reliable Method for Opportunistic Screening.
    Wu D; Zhou G; Jin P; Zhu J; Li S; Wu Q; Wang G; Sheng J; Wang J; Song L; Han X; Qian J
    J Mol Diagn; 2016 Jul; 18(4):535-45. PubMed ID: 27133379
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Urinary bladder cancer test: a new urinary tumor marker in the follow-up of superficial bladder cancer.
    Mungan NA; Vriesema JL; Thomas CM; Kiemeney LA; Witjes JA
    Urology; 2000 Nov; 56(5):787-92. PubMed ID: 11068302
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The role of haematuria in bladder cancer screening among men with former occupational exposure to aromatic amines.
    Pesch B; Nasterlack M; Eberle F; Bonberg N; Taeger D; Leng G; Feil G; Johnen G; Ickstadt K; Kluckert M; Wellhäusser H; Stenzl A; Brüning T;
    BJU Int; 2011 Aug; 108(4):546-52. PubMed ID: 21223477
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of a 5-Marker Blood Test for Colorectal Cancer Early Detection in a Colorectal Cancer Screening Setting.
    Werner S; Krause F; Rolny V; Strobl M; Morgenstern D; Datz C; Chen H; Brenner H
    Clin Cancer Res; 2016 Apr; 22(7):1725-33. PubMed ID: 26561557
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Current concepts of tumor markers in bladder cancer.
    Droller MJ
    Urol Clin North Am; 2002 Feb; 29(1):229-34. PubMed ID: 12109349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.